Hepatitis B Immunity Status among Healthcare Sciences Students, 20 Years after the Infantile Vaccination: The Most Appropriate Policy to Confer Full Protection.
Article Sidebar
Main Article Content
Abstract
= Author withdrawal on 18.10.2023 =
Background. During recent years, an increasing number of previously vaccinated children against hepatitis B (HBV) may begin activities as healthcare sciences students (HSS), so, at the higher risk of HBV infection. Therefore, documenting their immunity at before training was recommended. To evaluate their immunity status, as well as measuring the presence of immunological memory and protection through administering 1-to-3 additional doses of HBV vaccine among HSS who have been immunized at childhood, this study was conducted.
Subjects and Methods. The vaccination status of the accepted HSS was documented by reviewing their vaccination record card. HBV infection markers at before, and following 1-to3 dose of HBV vaccine were measured using ELISA. Simple descriptive statistical methods were used to analyze collected data.
Results. Totally, 274 HSS, 59.1% female, with mean age 23.8 years were included. Of those, 228 in infancy, and 46 within last 12-years have been immunized. From 228 infantile immunized students,103 with 1-to-3 doses of HBV vaccine were vaccinated. Of 125 non-boosted HSS, 64 preserved their protective antibody titers. The proportion of protected students and their antibody levels were increased significantly and approached to 96.8% following 3-doses of booster injection.
Conclusion. Nearly half of the vaccinated students had lost their protective antibody titers, but, the majority of them preserved their immunological memory, detected through anamnestic response to booster vaccination. To provide appropriate protection, universal vaccination with one-doses of HBV vaccine followed by serological monitoring to identify non-protected students for further management seems reasonable.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
References.
Schweitzer A, Horn J, Mikolajczyk RT, Ott JJ. Estimation of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. The Lancet.2015;386 (10003):1546-1556.
World Health Organization (WHO). Hwpatitis B Fact Sheet. 24 june 2022. www.who. Int
Deuffic-Burban S, Delarocque-Astagneau E, Abiteboul D, Bouvet E, Yazdanpanah Y. Blood-borne viruses in health care workers: prevention and management. J Clin Virol. 2011 Sep;52(1):4-10.
Swift MD, Behrman AJ. Vaccines for health care personnel’s. Myo Clin Prec. 2019;94(10): 2127-41.
Van Damme P, Ward J, Shouval D, Wierma S, Zanetti A. Hepatitis B vaccine, In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM; eds. Vaccines. 6th ed. Elsevier- Saunders 2018: 342-374.
Askarian M, Malekmekan L. The prevalence of needle sticks injuries among medical, dental, nursing, and midwifery students at the university teaching hospitals of Shiraz, Iran. Indian J Med Sci 2006;60(6): 227-232.
World Health Organization WHO. Immunization, Vaccines and Biologicals. Hepatitis B position paper. WKLY Epidemiol Rec. 2017;92(27):369-392.
Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, et al. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018;67(1):1-31.
Iranian Ministry of Health and Medical Education. Vice-chancellor for Health. Schedule and Guidelines of Immunization Approved by National Immunization Technical Advisory Group 2015. Ministry of Health and Medical Education, Tehran. Iran.
Dini G, Toletone A, Barberis I, Debarbieri N, Massa E, et al. Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: A cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy. Hum Vaccin Immunother. 2017 Feb;13(2):440-444.
Stefanati A, Bolognesi N, Sandri F, Dini G, Massa E, et al. Long-term persistency of hepatitis B immunity: an observational cross-sectional study on medical students and resident doctors. J Prev Med Hyg. 2019;60(3): E184-E190.
Bini C, Grazzini M, Chellini M, Mucci N, Arcangeli G, et al. Is hepatitis B vaccination performed at infant and adolescent age able to provide long-term immunological memory? An observational study on healthcare students and workers in Florence, Italy. Hum Vaccin Immunother. 2018;14(2):450-455.
Posuwan N, Vorayingyong A, Jaroonvanichkul V, Wasitthankasem R, Wanlapakorn N, et al. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity. PLoS One. 2018 Aug 20;13(8): e0202637.
Spradling PR, Xiang J, Williams R, Masunu-Faleafaga Y,Oulski T, Mahamud A,et al. Immunity to hepatitis B virus( HBV) infection two decades after implantation of universal infant hepatitis B vaccination: a association of detectable residual antibodies and response to a single dose. Clin Vaccine Immunol.2013; 20: 559-561.
Rahmani A, Montecucco A, Vitturi BK, Debarbieri N, Dini G, Durando P. Long-term effectiveness of hepatitis B vaccination in the protection of healthcare students in the highly developed countries: A systematic review and Meta- Analysis. Vaccines (Basel). 2022; 10(11):1841.
Doi H, Kanto T. Factors influencing the durability of hepatitis B vaccine responses. Vaccine. 2021;39(36): 5224-5230.
Dowran R, Malekzadeh M, Nourollahi T, SArkari B, Sarvari J. The prevalence of hepatitis B markers among students of Shiraz University of medical sciences. Adv Biomed Res. 2021; 10: 70.
Saffar H, Ajami A, Saffar MJ, Shojaei J, Sotudeh-Anvari M, etal. Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth; impact on the epidemiology of hepatitis B infection in Iran. Hepath Mon. 2014; 14(5): e17263.
Moghadami M, Dadashpour N, Mokhtari AM, Ebrahimi M, Mirghmadizadeh A. The effectiveness of the national hepatitis B vaccination program 25 years after its introduction in Iran: a historical cohort study. Braz J Infect Dis. 2019;23(6):419-426.
Saffar H, Khoshayand N, Parsaei MR, Ghorbani GR, Arabi M, Nadi-Gara AA, etal. High levels of vaccination and protection against hepatitis B with low rate of HCV infection markers among hospital health care personnel in north of Iran: a cross-sectional study. BMC Public Health. 2020;20:220.